These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7308991)

  • 41. Recurrence-free long-term survival after liver transplantation for hepatitis B using interferon-alpha pretransplant and hepatitis B immune globulin posttransplant.
    Tchervenkov JI; Tector AJ; Barkun JS; Sherker A; Forbes CD; Elias N; Cantarovich M; Cleland P; Metrakos P; Meakins JL
    Ann Surg; 1997 Sep; 226(3):356-65; discussion 365-8. PubMed ID: 9339942
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Quantitative relationship between HBeAg and DNA polymerase activity in sera from patients with chronic active hepatitis during a three-month period.
    Heijtink RA; van der Waart M; Weimar W; Schalm SW; Masurel N
    J Med Virol; 1980; 5(4):295-302. PubMed ID: 7229620
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment of viral hepatitis. b) Anti-virus agents].
    Matsushima T
    Hokkaido Igaku Zasshi; 1984 May; 59(3):238-44. PubMed ID: 6479842
    [No Abstract]   [Full Text] [Related]  

  • 44. [Correlation between HBeAg in the blood and HBcAg in hepatocyte nuclei in hepatitis B].
    Toti M; Alegente G; Almi P; Frosini G
    Ann Sclavo; 1981; 23(3):314-9. PubMed ID: 7041836
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis D virus (delta agent) superinfection in an endemic area of hepatitis B infection: immunopathologic and serologic findings.
    Lee SD; Wang JY; Wu JC; Tsai YT; Lo KJ; Lai KH; Tsay SH; Govindarajan S
    Scand J Infect Dis; 1987; 19(2):173-7. PubMed ID: 3616486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Relationship between serum HBV-DNA polymerase activity and HBe system: changes of DNA polymerase activity and transaminase].
    Saito S; Watanabe S; Yoshikawa A; Kamimura T; Ichida F
    Nihon Shokakibyo Gakkai Zasshi; 1984 May; 81(5):1223-9. PubMed ID: 6471535
    [No Abstract]   [Full Text] [Related]  

  • 47. Hepatitis B surface antigen/IgM complexes: relation to receptors for polymerized human serum albumin, hepatitis B virus (HBV) DNA polymerase activity and HBV markers.
    Mora I; Carreño V; Porres JC; Gutiez J; Guio CH
    Acta Virol; 1987 Mar; 31(2):116-25. PubMed ID: 2886020
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Hepatitis B virus antigens and antibodies in acute infection].
    Ketiladze ES; Zhilina NN; Vorozhbieva TE; Goldberg EZ; Farber NA
    Vopr Virusol; 1980; (2):232-6. PubMed ID: 7385794
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immune electron microscopic study of hepatitis B virus associated antigens in hepatocytes.
    Kojima T
    Gastroenterol Jpn; 1982 Dec; 17(6):559-75. PubMed ID: 7160600
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Changes in hepatitis B virus DNA polymerase in relation to the outcome of acute hepatitis type B.
    Alberti A; Diana S; Eddleston AL; Williams R
    Gut; 1979 Mar; 20(3):190-5. PubMed ID: 437551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recombinant leukocyte interferon treatment of chronic hepatitis B.
    Dusheiko G; Dibisceglie A; Bowyer S; Sachs E; Ritchie M; Schoub B; Kew M
    Hepatology; 1985; 5(4):556-60. PubMed ID: 4018728
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The significance of the HBe system in an area highly endemic for hepatitis B virus.
    Del Vecchio-Blanco C; Caporaso N; Balzano A; Ambrogio G; Aldershvile J; Juhl E; Nielsen JO
    Infection; 1983; 11(1):13-6. PubMed ID: 6840863
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chronic type B hepatitis: clinical course.
    Hoofnagle JH; Davis GL; Hanson RG
    Prog Clin Biol Res; 1983; 143():41-53. PubMed ID: 6669585
    [No Abstract]   [Full Text] [Related]  

  • 54. Differential distribution of hepatitis B core and E antigens in hepatocytes: analysis by monoclonal antibodies.
    Mondelli M; Tedder RS; Ferns B; Pontisso P; Realdi G; Alberti A
    Hepatology; 1986; 6(2):199-204. PubMed ID: 3514406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [HBeAg and anti-HBe in asymptomatic carriers of HBsAg and in various forms of hepatitis and liver cirrhosis].
    Kalinowska B; Nazarewicz-de Mezer T; Krawczyński K
    Przegl Epidemiol; 1984; 38(3):249-56. PubMed ID: 6528039
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum HBsAg, HBeAg, anti-HBe, and hepatitis B viral DNA in asymptomatic carriers in Taiwan.
    Chen DS; Lai MY; Lee SC; Yang PM; Sheu JC; Sung JL
    J Med Virol; 1986 May; 19(1):87-94. PubMed ID: 3701304
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B virus replication in steroid-treated severe HBsAg-positive chronic active hepatitis.
    Davis GL; Czaja AJ; Taswell HF; Ludwig J; Go VL
    Dig Dis Sci; 1985 Feb; 30(2):97-103. PubMed ID: 3967568
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Markers of viral replication in patients with chronic hepatitis B virus infection.
    Govindarajan S; Fong TL; Valinluck B; Edwards V; Redeker AG
    Am J Clin Pathol; 1988 Feb; 89(2):233-7. PubMed ID: 3341283
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Virus replication and liver disease in chronic hepatitis B virus infection.
    Alberti A; Tremolada F; Fattovich G; Bortolotti F; Realdi G
    Dig Dis Sci; 1983 Nov; 28(11):961-6. PubMed ID: 6628155
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of hepatitis B e antigen in pregnant women and patients with liver disease.
    Gill HH; Majumdar PD; Dhunjibhoy KR; Desai HG
    J Assoc Physicians India; 1995 Apr; 43(4):247-8. PubMed ID: 8713262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.